- 3.0Impact Factor
- 3.7CiteScore
- 21 daysTime to First Decision
Special Issues
Diseases publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Advances in Molecular Pathogenesis, Precision Medicine, and Artificial Intelligence in Hematologic Malignancies
Deadline: 31 December 2026
Immune-Mediated Thrombosis: Mechanisms, Vaccine Association, and Therapeutic Innovations
Deadline: 31 December 2026
From Monitoring to Management: Addressing Challenges in Type 1 and Type 2 Diabetes Care
Deadline: 31 October 2026
Gerontopsychiatry: Research, Perspectives, Innovation and Progress in Geriatric Psychiatry
Deadline: 31 October 2026
Recent Advances in Gastroenterology and Nutrition (2nd Edition)
Deadline: 1 October 2026
Mental Health Across the Lifespan: Integrating Multidisciplinary Perspectives
Deadline: 30 September 2026
Viral Hepatitis: Diagnosis, Treatment and Management—2nd Edition
Deadline: 30 September 2026
Microbiota in Human Disease
Deadline: 31 August 2026
Research Progress in Neurodegenerative Diseases
Deadline: 31 August 2026
Research Topics in Thrombosis-Inducing Diseases
Deadline: 31 August 2026
Integrating Molecular Genetics and Network Pharmacology: In Silico Approaches to Target Rare Disorders and Complex Diseases Using Natural or Chemical Compounds
Deadline: 31 August 2026
Mycobacterial Infections and Human Disease: Emerging Mechanisms and Therapeutic Strategies/Boundaries
Deadline: 1 August 2026
of 6

